Tyrosine kinase inhibitor resistant CML patients exhibit higher BMP4 production and its receptor BMPR1b to form a CML promoting autocrine loop (42). The gene discussed is BMPR1B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.